[ Introduction | The Reports | The Team | Contact ]

Publications by Biophoenix

This page shows all the major reports that Biophoenix' Directors have produced for other publishers, either together or separately.
See here for our own reports.

Just Out: Biosimilars and Biobetters: Positioning for a New Market (July, 2009) | Coming Next: Biochip and Microarray Testing (August, 2009)

Thumbnail images of our report covers, arranged from the most recent to the oldest. Position your mouse over any of them for more information; click to view the full-size cover and Table of Contents (and the Executive Summary for reports published in 2002 or later).

Kinases:  Highways to Drug Discovery. (Business Insights, 2009) In Press, 250 pages. The Future of RNAi Therapeutics:  Drug Pipelines and Prospects. (Business Insights, 2008) Ref. RBDD0025, 250 pages.
The Convergence of Biomarkers and Diagnostics: Therapy Area Analyses, Key Products and Future Trends (Business Insights Ltd, 2008) Ref. RBDD0021 250 pages. Innovations in Bioinformatics: Emerging Tools for Drug Discovery and Development (Business Insights Ltd, 2008) Ref. RBDD0020 250 pages. Biosimilars, Biogenerics, and Follow-On Biologics (Informa UK/Scrip, 2007) Ref BS1342, 234 pages. Immunomodulators (Business Insights Ltd, 2007) Ref RBDD0016, 346 pages. Livestock Performance Products and Markets (Informa UK/Animal Pharm, 2007) Ref SR254, 125 pages. Next Generation Protein Engineering and Drug Design (Business Insights Ltd, 2007) Ref. RBDD0013, 210 pages.
Molecular Diagnostics:  Effective Tools for Disease Management (3rd Edn). (D&MD Publications, 2006) Ref. N/A, 400 pages. Kinases: Advanced Strategies and Multiple Targets for Drug Discovery. (D&MD Publications, 2006) Ref. D&MD9217, 350 pages. Transmembrane Transporters: High Sales, High Potential (D&MD Publications, 2006) Ref D&MD9212, 250 pages. Stem Cells: Identifying Commercial Opportunities (Reuters Business Insights Ltd, 2006) In Press, 200 pages. Biomedical Patents In The Postgenomic Era: Proprietary Drug Targets And Therapies (D&MD, 2005) Ref. D&MD9149, 130 pages. The Emerging Drug Targets Outlook: An Analysis Of Novel Molecular Targets To Develop Innovative New Therapeutics (Reuters Business Insights Ltd, 2005) Ref. RBDD0006, 170 pages.
Angiogenesis Modulators: Strategies for Drug Discovery (D&MD, 2005) Ref. D&MD9148, 200 pages. Proteases As Drug Targets: Technologies and Opportunities for Drug Discovery. (D&MD Publications, 2004) Ref. D&MD9158, 250 pages. Molecular Diagnostics: Transforming Pharmaceuticals, Impacting New Markets (2nd Edn). (D&MD Publications, 2004) Ref. D&MD9147, 420 pages. Systems Biology: The future of integrated drug discovery. (PJB Publications, 2004) Ref. BS1255, 130 pages. Metabolic Syndrome: New Opportunities in Diagnostics and Therapeutics. (D&MD Publications, 2004) Ref. D&MD9135, 250 pages. Protein Kinases: Technologies and Opportunities for Drug Discovery. (D&MD Publications, 2003) Ref. D&MD9119, 300 pages.
Smarter Ways to Diagnose Cardiovascular and Heart Disease. (PJB Publications, 2003) Ref. CBS907, 200 pages. Immunodiagnostics and Nucleic Acid Testing Kits for the Veterinary Industry: Current status and future prospects. (PJB Publications, 2003) Ref. SR227, 140 pages. Angiogenesis: A therapeutic and market outlook (PJB Publications, 2002) Ref. BS1185E, 140 pages. Molecular Diagnostics: Transforming The Pharmaceuticals Market. (D&MD Publications, 2002) Ref. D&MD9081, 280 pages. The Outlook for the Biotech Sector in the Post-genomic Era. (Reuters/Datamonitor, 2002) Ref. RBHC0089, 250 pages. Lifestyle Drugs: New Opportunities in Obesity (Nicholas Hall & Company, 2001) 75 pages.
Lifestyle Drugs: New Opportunities in Sexual Dysfunction (Nicholas Hall & Company, 2001) 75 pages. Lifestyle Drugs: New Opportunities in Rejuvenation Pharmaceuticals (Nicholas Hall & Company, 2001) 75 pages. Nucleic Acid Testing: Technologies and Markets (PJB Publications, 2001) Ref CBS881, 200 pages. Pharmaplayers® (Biophoenix, first published in 2001, continuing ...) CD-ROM database. Theranostics: Commercial Opportunities for Diagnostic and Pharmaceutical Companies (D&MD Publications, 2001) Ref. 9017, 100 pages. Veterinary Immunodiagnostics - A Global Survey (PJB Publications, 2000) Ref. SR199E, 180 pages.
Angiogenesis Players (Financial Times Pharmaceuticals, 1999) 200 pages. Gene Therapy Players II (Financial Times Pharmaceuticals, 1999) Second Edition, 250 pages. Oligonucleotide Players (Financial Times Pharmaceuticals, 1999) 200 pages. Pharmacogenomics Players (Financial Times Pharmaceuticals, 1999) 200 pages. Cancer Therapeutics (Financial Times Pharmaceuticals, 1998) 250 pages. Gene Therapy Players (Financial Times Pharmaceuticals, 1997) 300 pages.
European Market for Drug Delivery Systems (Frost & Sullivan, 1994) Ref. E1860, 300 pages. European Market for Nonisotopic Immunoassay Products (Frost & Sullivan, 1994) Ref. E1861, 300 pages. DNA Diagnostics II (PJB Publications, 1993) Ref. CBS 396WC, 250 pages. In vitro Cancer Diagnostics II (PJB Publications, 1993) Ref. CBS 330, 248 pages. Diagnosis of Immune Dysfunction (PJB Publications, 1992) Ref. CBS 259, 146 pages. European Market for Allergy and Autoimmunity Tests (Frost & Sullivan, 1992) Ref. E1721, 250 pages.
Opportunities in Obesity, Anorexia, and Bulimia (PJB Publications, 1992) Ref. CBS 397, 160 pages. Biotechnology Made Simple IV (PJB Publications, 1991) Ref. BS 322, 278 pages. European Market for Hormone-Related Tests (Frost & Sullivan, 1991) Ref. E1480, 300 pages. Immunoassays in Clinical Endocrinology (PJB Publications, 1991) Ref. CBS 167, 128 pages. Scrip's Clinical Endocrinology Report (PJB Publications, 1991) Ref. BS 326, 128 pages. European Market for DNA Probe Diagnostic Products and Services (Frost & Sullivan, 1990) Ref. E1391, 320 pages.
New Horizons in Immunoassay (PJB Publications, 1990) Ref. CBS 108, 95 pages. Nonisotopic Immunoassay Markets in Europe: Reagents, Instrumentation, and Systems (Frost & Sullivan, 1990) 250 pages. World Market for Biotechnological Healthcare Products (Frost & Sullivan, 1989) Ref. W1252, 350 pages. European Market for in vitro Tests in Cancer Management (Frost & Sullivan, 1989) Ref. E1157, 300 pages. DNA Diagnostics (PJB Publications, 1988) Ref. CBS 84, 69 pages. DNA Probe Market in Europe (Frost & Sullivan, 1988) Ref. E1026, 300 pages.

If you still haven't found what you're looking for, you can search these ToCs (together with the remainder of the site) using the form provided below.

Any word (OR) All words (AND)
Most of our reports were written under contract to various third-party publishers, who therefore own the copyrights. We regret that we cannot sell such reports; you must contact the publisher in order to obtain copies. Older (pre-1999) reports are likely to be unobtainable.